AstraZeneca is capping out-of-pocket costs for inhalers and related medication at no more than $35 per month, the drugmaker announced Monday.

The 6-year-old has severe asthma and needs to use an inhaler twice a day. Lucas’ doctor switched him to a different inhaler, from Merck, which cost $80 a month.

Drugmaker Boehringer Ingelheim plans to cap the out-of-pocket costs for all its inhalers at $35 per month after coming under fire from Democratic lawmakers over pricing.

Drugmaker AstraZeneca will cap out-of-pocket costs at $35 for all its inhaler products, the company announced Monday. The cap is effective June 1 and will apply to the company’s entire range of ...

Drugmaker AstraZeneca said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States from June, following a similar move by rival ...

Some makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35. But those pledges don’t apply to daily inhalers used by the youngest kids, ...

The 4th major drug maker of asthma inhalers that have not currently announced a price cap is Teva Pharmaceuticals. Some monthly prescriptions are capped at $35 right now.

SOUTH BEND, Ind. (WSBT) – Lifesaving medicine at a life-changing price. Two major asthma inhaler drugmakers, Astra Zeneca and Boehringer Ingelheim, have capped their out-of-pocket price for ...

The 6-year-old has severe asthma and needs to use an inhaler twice a day. Lucas’ doctor switched him to a different inhaler, from Merck, which cost $80 a month.